Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Sidomulyo Selaras Tbk. (SDMU)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Sidomulyo Selaras Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Sidomulyo Selaras Tbk. diperdagangkan di Rp90 (kapitalisasi pasar 202,56 M, volume 24 jam 10,05 jt). Perbedaan utamanya: Sidomulyo Selaras Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SDMU | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 202,56 M |
Volume | — | 10,05 jt |
Lot | — | 100,53 rb |
Perputaran | — | 884,89 jt |
Harga Rata-rata | — | 88,02 |
Nilai Transaksi | — | 884,89 jt |
Harga Ekuilibrium Indikatif | — | 90 |
Volume Ekuilibrium Indikatif | — | 614 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Sidomulyo Selaras Tbk.
Sidomulyo Selaras Tbk (the company) was established on 13 Dec 1993 based on Notaries Deed No. 42 and the deed of establishment was approved by the the Ministry of Justice dated Feb 10, 1994. The Company’s articles of association has been amended several times, most recently by notarial deed No. 12 of F.Y Wijaya, S.H., dated Feb 28, 2011.
Selengkapnya di halaman SDMU →
